Ardent Health (NYSE:ARDT) Stock Gets Price Target Bump from Bank of America

Ardent Health (NYSE:ARDT – Get Free Report) had its target price lifted by analysts at Bank of America from $12.00 to $14.00 in a report issued on Friday, Marketbeat.com reports. The firm currently has an “underperform” rating on the stock. Bank of America‘s price target would suggest a potential downside of 21.15% from the stock’s current price.

A number of other brokerages also recently weighed in on ARDT. Guggenheim boosted their price target on Ardent Health from $13.00 to $14.00 and gave the stock a “buy” rating in a research report on Thursday, August 6th. Stephens raised their price objective on Ardent Health from $13.00 to $21.00 and gave the company an “overweight” rating in a research report on Friday, November 6th. Mizuho set a $21.00 price objective on Ardent Health in a research report on Wednesday. Leerink Partners reiterated an “outperform” rating and set a $14.00 target price on shares of Ardent Health in a research note on Friday, September 18th. Finally, Truist Financial lifted their target price on Ardent Health from $12.00 to $13.00 and gave the stock a “buy” rating in a research note on Thursday, August 6th. Seven equities research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, Ardent Health currently has an average rating of “Hold” and an average price target of $14.86.

Check Out Our Latest Analysis on ARDT

Ardent Health Stock Performance

Shares of Ardent Health stock traded up $0.07 during trading on Friday, hitting $17.75. 779,496 shares of the stock were exchanged, compared to its average volume of 780,413. The company has a current ratio of 2.13, a quick ratio of 2.03 and a debt-to-equity ratio of 0.60. The company has a fifty day moving average price of $12.14 and a 200-day moving average price of $10.33. The stock has a market capitalization of $2.50 billion, a price-to-earnings ratio of 17.24, a price-to-earnings-growth ratio of 3.20 and a beta of 0.58. Ardent Health has a 1-year low of $7.71 and a 1-year high of $18.57.

Ardent Health (NYSE:ARDT – Get Free Report) last issued its earnings results on Wednesday, November 4th. The company reported $0.31 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.23 by $0.08. Ardent Health had a net margin of 2.27% and a return on equity of 8.41%. The business had revenue of $1.62 billion during the quarter, compared to the consensus estimate of $1.60 billion. As a group, equities analysts predict that Ardent Health will post 1.05 EPS for the current fiscal year.

Institutional Trading of Ardent Health

A number of hedge funds have recently modified their holdings of the stock. Empowered Funds LLC grew its stake in Ardent Health by 1.0% in the 3rd quarter. Empowered Funds LLC now owns 556,586 shares of the company’s stock valued at $5,755,000 after buying an additional 5,293 shares during the last quarter. First Trust Advisors LP raised its holdings in Ardent Health by 5.9% in the 3rd quarter. First Trust Advisors LP now owns 595,710 shares of the company’s stock valued at $6,160,000 after acquiring an additional 33,432 shares during the period. Ieq Capital LLC lifted its position in Ardent Health by 27.7% during the third quarter. Ieq Capital LLC now owns 117,691 shares of the company’s stock worth $1,217,000 after acquiring an additional 25,500 shares during the last quarter. Russell Investments Group Ltd. lifted its position in Ardent Health by 3.2% during the third quarter. Russell Investments Group Ltd. now owns 69,827 shares of the company’s stock worth $724,000 after acquiring an additional 2,145 shares during the last quarter. Finally, R Squared Ltd boosted its holdings in shares of Ardent Health by 35.1% during the third quarter. R Squared Ltd now owns 16,468 shares of the company’s stock worth $170,000 after acquiring an additional 4,275 shares during the period.

About Ardent Health

(Get Free Report)

Ardent Health is a U.S. healthcare provider that operates hospitals and other care facilities. Its services include inpatient and outpatient care, emergency services, surgery, and specialty and primary care through affiliated clinics and medical groups. The company serves communities in several states, including New Mexico, Oklahoma, and Texas. Its regional health systems include Lovelace Health System, Hillcrest HealthCare System, and UT Health East Texas. Ardent Health was formerly known as Ardent Health Services and became a publicly traded company in 2023.

Further Reading

Analyst Recommendations for Ardent Health (NYSE:ARDT)

Receive News & Ratings for Ardent Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ardent Health and related companies with MarketBeat.com's FREE daily email newsletter.